Your browser doesn't support javascript.
loading
Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations.
Carneiro, Fábio; Saracino, Dario; Huin, Vincent; Clot, Fabienne; Delorme, Cécile; Méneret, Aurélie; Thobois, Stéphane; Cormier, Florence; Corvol, Jean Christophe; Lenglet, Timothée; Vidailhet, Marie; Habert, Marie-Odile; Gabelle, Audrey; Beaufils, Émilie; Mondon, Karl; Tir, Mélissa; Andriuta, Daniela; Brice, Alexis; Deramecourt, Vincent; Le Ber, Isabelle.
Afiliação
  • Carneiro F; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France; Hospital Garcia de Orta, Almada, Portugal; Centre de Référence des Démences Rares ou Précoces, IM2A, Département de Neurologie, AP-HP - Hôpital Pitié
  • Saracino D; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France; Centre de Référence des Démences Rares ou Précoces, IM2A, Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France; Aramis Project
  • Huin V; Univ. Lille, Inserm, CHU-Lille, Lille Neuroscience & Cognition, UMR-S1172, Team Alzheimer & Tauopathies, F-59000, Lille, France.
  • Clot F; Unité Fonctionelle de Neurogénétique Moléculaire et Cellulaire, Sorbonne Université, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
  • Delorme C; Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
  • Méneret A; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France; Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
  • Thobois S; Univ. Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; CNRS, Institut des Sciences Cognitives Marc Jeannerod, UMR 5229, Bron; Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Neurologie C, Bron, France.
  • Cormier F; Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
  • Corvol JC; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France; Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France; Centre d'Investigation Clinique Neurosciences, AP-HP - Hôpital Pitié-Sal
  • Lenglet T; Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France; Centre de Référence SLA-IdF, AP-HP - Hôpital Pitié Salpêtrière, Paris, France.
  • Vidailhet M; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France; Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
  • Habert MO; Sorbonne Université, CNRS, Inserm, Laboratoire d'Imagerie Biomédicale, LIB, Paris, AP-HP - Hôpital Pitié-Salpêtrière, Médecine Nucléaire, Paris, France.
  • Gabelle A; CMRR, Département de Neurologie, CHU de Montpellier, Inserm U1061, Université de Montpellier i-site MUSE, Montpellier, France.
  • Beaufils É; Université François Rabelais de Tours, CHRU de Tours, Tours, France; Inserm U1253, IBrain, Tours, France.
  • Mondon K; Université François Rabelais de Tours, CHRU de Tours, Tours, France.
  • Tir M; Département de Neurologie, Laboratoire de Neurosciences Fonctionnelles et Pathologies (UR UPJV 4559), Université d'Amiens et Université de Picardie Jules Verne, Amiens, France.
  • Andriuta D; Département de Neurologie, Laboratoire de Neurosciences Fonctionnelles et Pathologies (UR UPJV 4559), Université d'Amiens et Université de Picardie Jules Verne, Amiens, France.
  • Brice A; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
  • Deramecourt V; Université de Lille, Inserm U1172, CHU Lille, DistAlz, LiCEND, CNR-MAJ, Lille, France.
  • Le Ber I; Sorbonne Université, Paris Brain Institute - Institut du Cerveau - ICM, Inserm U1127, CNRS UMR 7225, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France; Centre de Référence des Démences Rares ou Précoces, IM2A, Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France; Département de
Parkinsonism Relat Disord ; 80: 73-81, 2020 11.
Article em En | MEDLINE | ID: mdl-32961397
INTRODUCTION: A phenotype of isolated parkinsonism mimicking Idiopathic Parkinson's Disease (IPD) is a rare clinical presentation of GRN and C9orf72 mutations, the major genetic causes of frontotemporal dementia (FTD). It still remains controversial if this association is fortuitous or not, and which clinical clues could reliably suggest a genetic FTD etiology in IPD patients. This study aims to describe the clinical characteristics of FTD mutation carriers presenting with IPD phenotype, provide neuropathological evidence of the mutation's causality, and specifically address their "red flags" according to current IPD criteria. METHODS: Seven GRN and C9orf72 carriers with isolated parkinsonism at onset, and three patients from the literature were included in this study. To allow better delineation of their phenotype, the presence of supportive, exclusion and "red flag" features from MDS criteria were analyzed for each case. RESULTS: Amongst the ten patients (5 GRN, 5 C9orf72), seven fulfilled probable IPD criteria during all the disease course, while behavioral/language or motoneuron dysfunctions occurred later in three. Disease duration was longer and dopa-responsiveness was more sustained in C9orf72 than in GRN carriers. Subtle motor features, cognitive/behavioral changes, family history of dementia/ALS were suggestive clues for a genetic diagnosis. Importantly, neuropathological examination in one patient revealed typical TDP-43-inclusions without alpha-synucleinopathy, thus demonstrating the causal link between FTD mutations, TDP-43-pathology and PD phenotype. CONCLUSION: We showed that, altogether, family history of early-onset dementia/ALS, the presence of cognitive/behavioral dysfunction and subtle motor characteristics are atypical features frequently present in the parkinsonian presentations of GRN and C9orf72 mutations.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transtornos Parkinsonianos / Proteína C9orf72 / Progranulinas Tipo de estudo: Etiology_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Parkinsonism Relat Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transtornos Parkinsonianos / Proteína C9orf72 / Progranulinas Tipo de estudo: Etiology_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Parkinsonism Relat Disord Assunto da revista: NEUROLOGIA Ano de publicação: 2020 Tipo de documento: Article